Target intelligence / Profile preview

Solute carrier family 20 member 1 pseudogene 2 (SLC20A1P2)

Target: SLC20A1P2
Molecular classification: Other (Pseudogene)

Overview

Solute carrier family 20 member 1 pseudogene 2 (SLC20A1P2) is a human pseudogene—an inactive genomic segment with sequence similarity to the solute carrier family 20 member 1 (SLC20A1) gene, which in its functional form encodes a sodium/phosphate cotransporter. However, SLC20A1P2 does not encode a functional protein, has no direct biological function, and is not a therapeutic target[3][1][5]. Pseudogenes are often the result of mutations that render them incapable of transcription or translation, though their sequences can provide insights into gene family evolution[5].

Mechanism of action

No mechanisms of action exist for drugs targeting this pseudogene.

Beyond the preview

Go deeper on Solute carrier family 20 member 1 pseudogene 2 (SLC20A1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 20 member 1 pseudogene 2 (SLC20A1P2).

Explore the full profile